Toward cellular and tissue selective inhibition of histone deacetylases (HDAC): Development of cellular- and isoform-selective HDAC probes

被引：0
|
作者：
Petukhov, Pavel [2 ]
Hanigan, Thomas [1 ]
Kastrati, Irida [3 ]
Frasor, Jonna [3 ]
机构：
[1] Univ Illinois, Med Chem, Chicago, IL USA
[2] Univ Illinois, Med Chem & Pharmacognosy, Chicago, IL USA
[3] Univ Illinois, Physiol & Biophys, Chicago, IL USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2015年 / 249卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
214
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Pharmacological Inhibition Of Histone Deacetylase (HDAC) 1, 2 Or 3 Have Distinct Effects On Cellular Viability, Erythroid Differentiation, and Fetal Globin (HbG) Induction
    Shearstone, Jeffrey R.
    van Duzer, John H.
    Jones, Simon S.
    Jarpe, Matthew
    [J]. BLOOD, 2013, 122 (21)
  • [42] Isoform-Selective HDAC Inhibitor Mocetinostat (MGCD0103) Alleviates Myocardial Ischemia/Reperfusion Injury Via Mitochondrial Protection Through the HDACs/CREB/PGC-1α Signaling Pathway
    Wang, Kaihao
    Tang, Ruijie
    Wang, Siyuan
    Xiong, Yuyan
    Wang, Wenyao
    Chen, Guihao
    Zhang, Kuo
    Li, Ping
    Tang, Yi-Da
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 79 (02) : 217 - 228
  • [43] Combinatorial efficacy of anti-PD1 treatment and selective histone deacetylase 6 (HDAC6) inhibition in chronic lymphocytic leukemia (CLL)
    Maharaj, Kamira
    Powers, John
    Achille, Alex
    Sahakian, Eva
    Pinilla-Ibarz, Javier
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [44] Novel biphenyl-based scaffold as potent and selective histone deacetylase 6 (HDAC6) inhibitors: Identification, development and pharmacological evaluation
    Xu, Xi
    Zhang, Di
    Zhao, Tengteng
    Wang, Min
    Li, Yu
    Du, Qianming
    Kou, Junping
    Li, Zhiyu
    Bian, Jinlei
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 233
  • [45] Histone deacetylase inhibitors derived from 1,2,3,4-tetrahydropyrrolo[1,2-a] pyrazine and related heterocycles selective for the HDAC6 isoform
    Blackburn, Christopher
    Barrett, Cynthia
    Brunson, Mable
    Chin, Janice
    England, Dylan
    Garcia, Kris
    Gigstad, Kenneth
    Gould, Alexandra
    Gutierrez, Juan
    Hoar, Kara
    Rowland, R. Scott
    Tsu, Christopher
    Ringeling, John
    Wager, Krista
    Xu, He
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (23) : 5450 - 5454
  • [46] New insights into possible HDAC inhibitor resistance in DLBCL - Comment on 'defining cellular responses to HDAC-selective inhibitors reveals that efficient targeting of HDAC3 is required to elicit cytotoxicity and overcome naive resistance to pan-HDACi in diffuse large B cell lymphoma'
    Kiesslich, Tobias
    Mayr, Christian
    Bekric, Dino
    Neureiter, Daniel
    [J]. TRANSLATIONAL ONCOLOGY, 2024, 44
  • [47] Defining cellular responses to HDAC-selective inhibitors reveals that efficient targeting of HDAC3 is required to elicit cytotoxicity and overcome naïve resistance to pan-HDACi in diffuse large B cell lymphoma
    Havas, Aaron P.
    Tula-Sanchez, Ana A.
    Steenhoek, Hailey M.
    Bhakta, Anvi
    Wingfield, Taylor
    Huntley, Matthew J.
    Nofal, Angela S.
    Ahmed, Tasmia
    Jaime-Frias, Rosa
    Smith, Catharine L.
    [J]. TRANSLATIONAL ONCOLOGY, 2024, 39
  • [48] Pharmacodynamic effect of MGCD0103, an oral isotype-selective histone deacetylase (HDAC) inhibitor, on HDAC enzyme inhibition and histone acetylation induction in phase I clinical trials in patients (pts) with advanced solid tumors or non-Hodgkin's lymphoma (NHL)
    Kalita, A
    Maroun, C
    Bonfils, C
    Gelmon, K
    Siu, LL
    Tolcher, A
    Carducci, M
    Besterman, JM
    Reid, GK
    Li, Z
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 869S - 869S
  • [49] Development of Selective Histone Deacetylase 6 (HDAC6) Degraders Recruiting Von Hippel-Lindau (VHL) E3 Ubiquitin Ligase
    Yang, Ka
    Wu, Hao
    Zhang, Zhongrui
    Leisten, Eric D.
    Nie, Xueqing
    Liu, Binkai
    Wen, Zhi
    Zhang, Jing
    Cunningham, Michael D.
    Tang, Weiping
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (04): : 575 - 581
  • [50] Synthesis of novel selective histone deacetylase inhibitors for the development of a suitable 18F-labelled radiotracer for the molecular imaging of HDAC1 in brain tumours
    Clauss, Oliver
    Toussaint, Magali
    Schaeker-Huebner, Linda
    Wenzel, Barbara
    Deuther-Conrad, Winnie
    Dukic-Stefanovic, Sladjana
    Ludwig, Friedrich-Alexander
    Guendel, Daniel
    Teodoro, Rodrigo
    Kopka, Klaus
    Brust, Peter
    Hansen, Finn
    Scheunemann, Matthias
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S215 - S216
12345